Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55375515 in Healthy Participants
Clinical trial NCT02623491 · COMPLETED
Trial details
- NCT number
- NCT02623491
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2016-09-01
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.